loadpatents
name:-0.018021821975708
name:-0.014513969421387
name:-0.0025410652160645
Lu; Henry Patent Filings

Lu; Henry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lu; Henry.The latest application filed is for "network provisioning".

Company Profile
1.15.14
  • Lu; Henry - Herndon VA
  • Lu; Henry - Malibu CA
  • Lu; Henry - Westfield IN US
  • Lu; Henry - Carlsbad CA US
  • Lu; Henry - Bloomington IN
  • Lu; Henry - Foster City CA
  • Lu, Henry - Foster CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Network Provisioning
App 20190208458 - LYNN, JR.; THOMAS WILLIAM ;   et al.
2019-07-04
Network provisioning
Grant 10,070,369 - Lynn, Jr. , et al. September 4, 2
2018-09-04
Method and apparatus for sharing geographically significant information
Grant 8,838,384 - Daily , et al. September 16, 2
2014-09-16
Network Provisioning
App 20140185536 - Lynn, JR.; Thomas William ;   et al.
2014-07-03
Multi-layer slides for analysis of urine sediments
Grant 8,462,332 - Pugia , et al. June 11, 2
2013-06-11
Geo-coded spatialized audio in vehicles
Grant 8,422,693 - Daily , et al. April 16, 2
2013-04-16
Sample Analysis System And Method Of Use
App 20130041236 - Pugia; Michael J. ;   et al.
2013-02-14
Multi-Layer Slides for Analysis of Urine Sediments
App 20110149277 - Pugia; Michael J. ;   et al.
2011-06-23
Benzisothiazoles useful for treating or preventing HCV infection
Grant 7,776,847 - Hong , et al. August 17, 2
2010-08-17
Heterotricyclic compounds for use as HCV inhibitors
Grant 7,569,580 - Thota , et al. August 4, 2
2009-08-04
Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
Grant 7,514,434 - Goff , et al. April 7, 2
2009-04-07
Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
Grant 7,498,353 - Singh , et al. March 3, 2
2009-03-03
Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
Grant 7,410,979 - Lu August 12, 2
2008-08-12
Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
App 20070004723 - Goff; Dane ;   et al.
2007-01-04
Substituted diphenyl heterocycles useful for treating HCV infection
Grant 7,153,880 - Singh , et al. December 26, 2
2006-12-26
Heterocyclic Anti-Viral Compounds Comprising Metabolizable Moieties And Their Uses
App 20060247287 - Singh; Rajinder ;   et al.
2006-11-02
Benzisothiazoles useful for treating or preventing HCV infection
App 20060229294 - Hong; Hui ;   et al.
2006-10-12
Heterotricylic compounds for use as HCV inhibitors
App 20050282850 - Thota, Sambaiah ;   et al.
2005-12-22
Methods for identifying polypeptide factors interacting with RNA
Grant 6,927,031 - Lu , et al. August 9, 2
2005-08-09
Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
App 20050129659 - Lu, Henry
2005-06-16
Methods of identifying HCV NS5B polymerase inhibitors and their uses
App 20050009877 - Lu, Henry
2005-01-13
Substituted diphenyl heterocycles useful for treating HCV infection
App 20040236112 - Singh, Rajinder ;   et al.
2004-11-25
Substituted diphenyl heterocycles useful for treating HCV infection
Grant 6,759,538 - Singh , et al. July 6, 2
2004-07-06
Methods for identifying polypeptide factors interacting with RNA
App 20030194712 - Lu, Henry ;   et al.
2003-10-16
Substituted diphenyl heterocycles useful for treating HCV infection
App 20030165561 - Singh, Rajinder ;   et al.
2003-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed